Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

2.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

4.

Pharmacokinetics and bioavailability of ST 1435 administered by different routes.

Noé G, Salvatierra A, Heikinheimo O, Maturana X, Croxatto HB.

Contraception. 1993 Dec;48(6):548-56.

PMID:
8131396
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk